Skip to main content

par 210 par 210 Pill - orange & white capsule/oblong, 23mm

Pill with imprint par 210 par 210 is Orange & White, Capsule/Oblong and has been identified as Propafenone Hydrochloride Extended Release 325 mg. It is supplied by Par Pharmaceutical Inc.

Propafenone is used in the treatment of Atrial Fibrillation; Wolff-Parkinson-White Syndrome; Atrial Flutter; Ventricular Tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for par 210 par 210

Propafenone hydrochloride extended release 325 mg par 210 par 210
Propafenone hydrochloride extended release 325 mg par 210 par 210

Propafenone Hydrochloride Extended Release

par 210 par 210
325 mg
Orange & White
23.00 mm
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc
Inactive Ingredients
lactose anhydrous, magnesium stearate, povidone, FD&C Blue No. 1, gelatin, titanium dioxide, D&C Yellow No. 10, ferrosoferric oxide, butyl alcohol, propylene glycol, FD&C Blue No. 2, FD&C Red No. 40, shellac, alcohol, water, ethylcellulose

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
49884-0210 Par Pharmaceutical, Inc.
68084-0917 Amerisource Health Services
42291-0546 AvKare, Inc.

Get help with Imprint Code FAQs.

Related images for "par 210 par 210"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.